Cuadrado-tejedor et al. (2018) investigated the effect of a simultaneous inhibitor of HDAC6 and PDE5, specifically compound CM-414, on HDACs and other AD-related proteins. The gene discussed is PDE5A; the disease is Alzheimer disease.